Table 1.
IL-1α (mean ± SD) n = 5 | Protein (intensity) | ΔCt: mRNA | 2-ΔΔCt |
---|---|---|---|
Primary EC (control) | 4678.6 ± 473 | 14.3 ± 0.4 | |
RL-952 | 4948.3 ± 167 | 14.4 ± 0.6 | 1.1 |
TOV-112D | 5217.1 ± 391 | 13.6 ± 0.1 | 1.3 |
TOV-21G | 11320.1 ± 391* | 13.2 ± 0.2 | 1.9* |
OV-90 | 3897.6 ± 590 | 15 ± 0.6 | 0.8 |
IL-1β (mean ± SD) n = 5 | |||
Primary EC (control) | 11.4 ± 0.6 | ||
RL-952 | 10.8 ± 0.4 | 1.3 | |
TOV-112D | 10.0 ± 0.3 | 2.0* | |
TOV-21G | 10.7 ± 0.3 | 1.4 | |
OV-90 | 9.9 ± 0.2 | 2.2* | |
IL-1RA (mean ± SD) n = 5 | |||
Primary EC (control) | 6921.1 ± 611 | 16.8 ± 0.7 | |
RL-952 | 8391.3 ± 241 | 15.9 ± 0.1 | 1.2 |
TOV-112D | 2101.6 ± 352* | 18.9 ± 0.6 | 0.2* |
TOV-21G | 8798.1 ± 571* | 16.1 ± 0.4 | 1.3 |
OV-90 | 13251.6 ± 495 | 15.9 ± 0.3 | 1.4 |
2-ΔΔCt: fold differences of mRNA expression.
* P < 0.05, comparison to control (primary endometrial cells).